ORGS
Orgenesis Inc

831
Mkt Cap
$814,701.00
Volume
100.00
52W High
$5.89
52W Low
$0.0001
Price
$0.15
ORGS Fundamentals
Prev Close
$0.15
Open
$0.15
50D MA
$0.3754
Beta
548.17
Avg. Volume
2,567.23
Orgenesis, Inc. is a biotechnology company, which engages in the development, manufacturing, and provision of technologies, and services in the cell and gene therapy industry. It operates through the following segments: Octomera and Therapies. The Octomera segment refers to the point of care services. The Therapies segment is involved in therapeutic development operations. The company was founded by Sarah Ferber on June 5, 2008 and is headquartered in Germantown, MD.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Orgenesis Inc?
What is the 52-week high for Orgenesis Inc?
What is the 52-week low for Orgenesis Inc?
What is Orgenesis Inc stock price today?
What was Orgenesis Inc stock price yesterday?
What is the 50-day moving average of Orgenesis Inc?

Latest ORGS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.